]>
IRCT20150919024080N14 IRCT 2019-12-07 Khoram-Abad University of Medical Sciences The effect of Melissa on stress and hemodynamic parameters The effect of aromatherapy with Melissa Officinalis essene on Stress and Hemodynamic parameters of patients with acute coronary syndrome at Emergency unit 2019-10-23 anticipated 72 Complete https://irct.ir/trial/43430 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Patients who meet the inclusion criteria will be assigned to the two study groups using stratified randomized block design (to match the two groups according to sex and severity of pain). In this way, the first stage of the patient's sex is considered and in different sex the severity of pain in the categories 3-6.9 and 7-10 is considered as the second floor and within the patient classes as 4 or 6 blocks with The use of the computer will be randomly assigned to the two study groups, Blinding description: Melissa Officinalis essence and placebo will be poured into Barry's similar dark glass containers by Barij essence Company and the dishes will be coded by a person who has no role in the study and will be covered by a black bar. The code of the essential oil containers will remain with the research partner until the end of the analysis. The researcher, the statistical consultant, the interventionist, and study participants will be unaware of the contents of the dishes. The therapist will also use a nasal clip for 10 minutes during aromatherapy. 3 Condition 1: Acute coronary syndrom. Condition 2: Stress. Condition 3: Aromatherapy. Condition 4: Mean atrial pressure and Heart rate. Intervention 1: Intervention group: Melissa officinalis essence 80%, one drop, two times and 90 minutes away،For 10 minutes at a time، Inhaler with oxygen mask، Adonis Pharmaceutical Company. Intervention 2: Control group: 2% sunflower oil, two drop, two times and 90 minutes away،For 10 minutes at a time، Inhaler with oxygen mask، Adonis Pharmaceutical Company. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information
public Atefe Veiskaramian
km 5 Road of Khorram Abad - Boroujerd - opposite to the Kahrizak village- Integrated Lorestan Medica
Khorammabad Iran (Islamic Republic of) 381351698 +98 916 661 8071 a.veiskaramian67@gmail.com Khoram-Abad University of Medical Sciences scientific Mohammad Gholami
km 5 Road of Khorram Abad - Boroujerd - opposite to the Kahrizak village- Integrated Lorestan Medica
Khorammabad Iran (Islamic Republic of) 381351698 +98 912 509 1279 gholami.m@lums.ac.ir Khoram-Abad University of Medical Sciences Iran (Islamic Republic of) Definitive diagnosis of acute coronary syndrome by a specialist based on evidence based electrocardiogram and clinical signs and troponin index No respiratory disease such as asthma and COPD and allergies or allergies to plants Entering the emergency department without cardiac arrest Vigilance and Awareness of place, time and person No history of head trauma and seizure No history of confirmed mental illness No opium and alcohol addiction No history of PTSD in during the last six months No history of using other complementary therapies for at least one month before intervention No disruption of sense of smell Mean arterial blood pressure more than 90 and heart rate more than 60 Patients with chest pain severity of 3 and more based on visual analogue scale (VAS) Age over 35 and under 65 years 35 years 65 years Both Patients Candidate for primary PCI Patient's unwillingness to continue participation Unstable hemodynamic (20% change compared to time of start intervention) Incidence of arrhythmias and allergic and respiratory problems during intervention Transfer patients from the emergency department to the intensive care unit in less than 3 hours Patient connection to mechanical ventilation I21.4 F43.0 Non-ST elevation (NSTEMI) myocardial infarction Acute stress reaction Other Placebo Intervention group: Melissa officinalis essence 80%, one drop, two times and 90 minutes away،For 10 minutes at a time، Inhaler with oxygen mask، Adonis Pharmaceutical Company Control group: 2% sunflower oil, two drop, two times and 90 minutes away،For 10 minutes at a time، Inhaler with oxygen mask، Adonis Pharmaceutical Company Stress score in DASS-21 questionnaire. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: DASS-21 Stress Questionnaire. Mean Atrial Pressure. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine. Heart rate. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine. Threat perception score. Timepoint: Before and the end of intervention. Method of measurement: Threat Perception Questionnaire. قبل از مداخلهpain. Timepoint: Before the intervention, 5 and 15 minutes after the intervention in two aromatherapy treatments. Method of measurement: Visual Analogue Scale. Doesnt have Approved 2019-09-07 Ethics committee of Lorestan University of Medical Sciences Iran University of Medical Sciences, Lorestan, Khorram Abad, 5 Km. Khorram Abad Lorestan Iran (Islamic Republic of)